Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer.
Year: 1999
Type: article
Study design: Observational Study
Source: PubMed
Authors: C T Lee, P Capodieci, I Osman, M Fazzari, J Ferrara, H I Scher, C Cordon-Cardo
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2140150237
